An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum
Clinical trial NCT03137160 · COMPLETED
Trial details
- NCT number
- NCT03137160
- Sponsor
- Ohio State University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-04
- Primary completion
- 2018-08-16
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.